Shanghai Fosun Pharmaceutical : Nine-Month Net Profit Rose 20%

By Yifan Wang

Shanghai Fosun Pharmaceutical (Group) Co. said its net profit for the first nine months of the year rose 20%, thanks to better sales and cost efficiency.

Net profit was 2.48 billion yuan ($368.6 million) for the January-September period, the Chinese drug maker said Thursday.

Revenue rose 4.1% from a year earlier to CNY22.10 billion but operating expenses declined, leading to higher profitability that supported the stronger bottom-line growth.

Write to Yifan Wang at [e-mail]

(END) Dow Jones Newswires

10-29-20 0558ET